BOSTON--(BUSINESS WIRE)--Lose It!, the highly effective weight loss app that has helped more than 30 million users lose over 50 million pounds, today announces the launch of embodyDNA, the first DNA-based weight loss plan to give actionable, personalized results through an interactive in-app experience. Lose It! developed embodyDNA, which offers customized recommendations on food/beverage consumption and physical activities, in collaboration with Helix, a personal genomics company, that today launched the first online marketplace for DNA-powered products.
To get started, users visit http://embodydna.com and order an embodyDNA kit for a one-time cost of $189.99. Once a user mails in their saliva sample, Helix reads their DNA and Lose It! translates the data into insights, delivering them to the user directly in the Lose It! app along with personalized weight loss, nutrition, fitness, and food sensitivity recommendations. embodyDNA also identifies patterns in users’ Lose It! history and provides feedback on their recorded behaviors, empowering members to optimize their daily habits and reach their weight loss goals.
“Lose It! is proud to be at the forefront of innovation in the weight loss category, offering a new way to help our users reach their goals,” said Lose It! CEO and cofounder Charles Teague. “Given that nearly two-thirds of Americans are overweight or obese, we are excited about the potential that embodyDNA has to help millions of people lose weight and maintain healthy behaviors that work for them. We are proud to be a part of Helix’s revolutionary online marketplace for DNA-powered products, and excited to bring this new technology to our millions of users.”
Lose It! continues to bring cutting-edge technology to the weight loss space, helping people achieve their health goals. Last year, Lose It! launched Snap It, a tool that uses machine learning to identify food and corresponding nutritional information from a photo. Now, with the launch of embodyDNA, Lose It! will deliver an even more personalized path to weight loss success.
“Lose It! is an innovator in weight loss technology and we’re excited to partner with them to further personalize their products with the power of DNA,” said Justin Kao, Co-Founder and SVP of Helix. “The Helix marketplace thrives on offering a robust and diverse selection of products like embodyDNA, which have tremendous personal utility to consumers, and in turn increase the overall utility of personal genomics in everyday life.”
In addition to embodyDNA, the Helix marketplace will host a diverse range of DNA-powered products focused on health, fitness, nutrition, family, ancestry and entertainment. The Helix marketplace can be accessed at www.Helix.com. High-resolution images are available at www.helix.com/press.
About Lose It!
Lose It! is mobilizing the world to achieve a healthy weight. By providing the most comprehensive, personal, app-based weight loss program, Lose It! has helped more than 30 million members shed more than 50 million pounds. Available on iOS and Android devices, Lose It! empowers members to live healthier lives and achieve their weight loss goals through motivation and challenges, coaching, overall health management, and the insights that come from tracking and monitoring daily calories, exercise, and nutrition. To learn more about Lose It!, visit www.loseit.com.
About Helix
Helix is a personal genomics company with a simple but powerful mission: to empower every person to improve their life through DNA. We’ve created the first marketplace for DNA-powered products where people can explore diverse and uniquely personalized products developed by high-quality partners. Helix handles sample collection, DNA sequencing, and secure data storage so that our partners can integrate DNA insights into products across a range of categories, including ancestry, entertainment, family, fitness, health and nutrition. From profound insights to just-for-fun discoveries, Helix is here to help people live a fuller life. Helix is headquartered in the San Francisco Bay Area, and has a CLIA- and CAP-accredited Next Generation Sequencing lab powered by Illumina (NASDAQ:ILMN) NGS technology, in San Diego. Helix was created in 2015 with founding support from Illumina, its largest shareholder. Learn more at www.helix.com.
Helix, the Helix logo and Exome+ are trademarks of Helix Opco, LLC. All other trademarks referenced herein are the property of their respective owners.
